Combination of Carboplatin and Bevacizumab Is an Efficient Therapeutic Approach in Retinoblastoma Patient-Derived Xenografts-Reference-Cited by-同舟云学术

Combination of Carboplatin and Bevacizumab Is an Efficient Therapeutic Approach in Retinoblastoma Patient-Derived Xenografts

Published:2016-09-20 Issue:11 Volume:57 Page:4916
ISSN:1552-5783
Container-title:Investigative Opthalmology & Visual Science
language:en
Short-container-title:Invest. Ophthalmol. Vis. Sci.

Author:

Assayag Franck¹,Nicolas André²,Vacher Sophie³,Dehainault Catherine³,Bieche Ivan³,Meseure Didier²,Aerts Isabelle⁴,Cassoux Nathalie⁵,Houdayer Claude⁶,Doz François⁷,Decaudin Didier⁸

Affiliation:

1. Laboratory of Preclinical Investigation, Translational Research Department, Paris Sciences et Lettres (PSL) University, Institut Curie, Paris, France

2. Department of Tumor Biology, Institut Curie, Paris, France

3. Department of Genetics, Institut Curie, Paris, France

4. Department of Pediatric and Young Adult Oncology, Institut Curie, Paris, France

5. Department of Surgical Oncology and Ophthalmology, Institut Curie, Paris, France

6. Department of Genetics, Institut Curie, Paris, France 6INSERM U830, Research Centre, Institut Curie, Paris Sciences et Lettres (PSL) University, Paris, France 7Université Paris Descartes, Sorbonne Paris Cité, Paris, France

7. Department of Pediatric and Young Adult Oncology, Institut Curie, Paris, France 7Université Paris Descartes, Sorbonne Paris Cité, Paris, France

8. Laboratory of Preclinical Investigation, Translational Research Department, Paris Sciences et Lettres (PSL) University, Institut Curie, Paris, France 8Department of Medical Oncology, Institut Curie, Paris, France

Publisher

Association for Research in Vision and Ophthalmology (ARVO)

Subject

General Medicine

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Potential of Aqueous Humor Sampling in Diagnosis, Prognosis, and Treatment of Retinoblastoma;Investigative Opthalmology & Visual Science;2024-01-05

2. MicroRNA‑34a inhibits the proliferation and promotes the chemosensitivity of retinoblastoma cells by downregulating Notch1 expression;Molecular Medicine Reports;2020-06-15

3. Establishment of chemosensitivity tests in triple-negative and BRCA-mutated breast cancer patient-derived xenograft models;PLOS ONE;2019-12-10

4. Clinicohistopathological implications of MMP/VEGF expression in retinoblastoma: a combined meta-analysis and bioinformatics analysis;Journal of Translational Medicine;2019-07-16

5. Non-coding and Coding Transcriptional Profiles Are Significantly Altered in Pediatric Retinoblastoma Tumors;Frontiers in Oncology;2019-04-16